Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases.
Kawaguchi
Takumi
T
Harada
Masaru
M
Arimatsu
Hidetoshi
H
Nagata
Shuichiro
S
Koga
Yuriko
Y
Kuwahara
Reiichiro
R
Hisamochi
Akiko
A
Hino
Teruko
T
Taniguchi
Eitaro
E
Kumemura
Hiroto
H
Hanada
Shinichiro
S
Maeyama
Michiko
M
Koga
Hironori
H
Tomiyasu
Nobuo
N
Toyomasu
Hiroyuki
H
Kawaguchi
Motonari
M
Kage
Masayoshi
M
Kumashiro
Ryukichi
R
Tanikawa
Kyuichi
K
Sata
Michio
M
D000328:Adult; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D019587:Dietary Supplements; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D018490:Serotonin Agents / Q000009:adverse effects*; D012720:Severity of Illness Index
D019440:Anti-Obesity Agents; D018490:Serotonin Agents; D005277:Fenfluramine